PedAM
Pediatric Disease Annotations & Medicines
| Disease | artery disease |
| Phenotype | |hypertension |
| Sentences | 57 |
| PubMedID- 24155103 | The following candidate variables associated with the 5-drug combination therapy at discharge on univariate analyses (p < 0.05) were entered into the model: age, diabetes, hypertension, hypercholesterolaemia, family history of coronary artery disease, previous coronary artery bypass grafting (cabg), enrolment into the registry at the interventional centre, unstable angina (ua), and stemi. |
| PubMedID- 24126178 | hypertension is commonly associated with peripheral artery disease. |
| PubMedID- 25840695 | Treatment of hypertension in patients with coronary artery disease: a scientific statement from the american heart association, american college of cardiology, and american society of hypertension. |
| PubMedID- 25705301 | Material and methods: to assess the current incidence and meaning of hypertension associated with atherosclerotic coronary artery disease we performed a cross-sectional analysis that included 402 patients with left bundle branch block, admitted between january 2011 and june 2013 in the cardiovascular diseases institute iasi, romania. |
| PubMedID- 22711750 | Age, sex, smoking, diabetes mellitus, body mass index, hypertension stage, and history of heart failure, coronary artery disease, and cerebrovascular disease were predictive of pad prevalence. |
| PubMedID- 25616558 | Significant difference between the groups (p <0.05) was detected for hypertension, dyslipidemia, family history of mi/stroke/tia, coronary artery disease, myocardial infarction, heart failure, peripheral artery disease, atrial fibrillation, chronic kidney disease, and liver disease.table 2treatment characteristics of study participantscharacteristicregular medical carecoagulation servicetotal amount of treatment days4,681,125931,579total amount of international normalized ratio (inr) values29,74819,207median time between inr measurements [days; interquartile range]17.0 (10.7/26.0)15.2 (11.4/18.8)self-management of oral anticoagulant therapy13.5 (271)9.5 (72)physician in chargegeneral practitioner, % (no. |
| PubMedID- 24816041 | Results: sex, smoking, proteinuria, hypertension, and history of stroke and coronary artery disease were common independent risk factors for the decrease of abi and tbi; their impacts on abi and tbi were not significantly different. |
| PubMedID- 26373919 | Introduction: it is important to know how to treat hypertension in patients with coronary artery disease (cad). |
| PubMedID- 19573937 | A 75-year-old man with hypertension, hypercholesterolemia and history of coronary artery disease was admitted to the hospital because of sudden loss of consciousness. |
| PubMedID- 21688136 | Accuracy of dual-source ct to identify significant coronary artery disease in patients with uncontrolled hypertension presenting with chest pain: comparison with coronary angiography. |
| PubMedID- 26205991 | A new guideline on treatment of hypertension in those with coronary artery disease: scientific statement from the american heart association, american college of cardiology, and american society of hypertension about treatment of hypertension in patients with coronary artery disease. |
| PubMedID- 22430321 | [arterial hypertension in patients with coronary artery disease]. |
| PubMedID- 25951606 | Egfr on the other hand is significantly associated with cfr, even after controlling for multiple covariates including diabetes, hypertension, dyslipidemia and severity of obstructive coronary artery disease. |
| PubMedID- 20961824 | Epidemiological, controlled human exposure, and toxicological studies examined whether hypertension, conditions associated with coronary artery disease [cad; i.e., ischemic heart disease (ihd), mi, atherosclerosis], and chf modulate pm-related health effects. |
| PubMedID- 21860776 | Criteria for exclusion were as follows: age greater than 60 years, atrial fibrillation, diabetes mellitus, systemic arterial hypertension, history of coronary artery disease, moderate to severe valvular heart disease, cardiomyopathy, history of previous hyperthyroidism, previous use of antithyroid agents, and lipid lowering therapy in last 6 months. |
| PubMedID- 25664116 | High prevalence of coronary artery disease in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease was found. |
| PubMedID- 24299915 | Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. |
| PubMedID- 25898844 | Several experimental and clinical studies have highlighted the pro-fibrotic role of opn in cardiovascular disease.6,7,11 plasma levels of opn are elevated in essential hypertension, and in patients with coronary artery disease and re-stenosis.12–14 opn levels are predictive of adverse cardiac events in patients with chronic stable angina.15 kato et al.14 could show that pre-procedural opn predicts re-stenosis in patients undergoing percutaneous coronary intervention. |
| PubMedID- 24696678 | Resveratrol's cardioprotective effects, such as improved endothelium function, decreased left ventricular and vascular remodeling, and a decrease in ischemia-induced arryhthmias have been demonstrated in numerous chronic rodent models of diabetes and hypertension [8, 16–18], in patients with coronary artery disease [19] and overweight and/or obese patients [20]. |
| PubMedID- 25126308 | Randomized controlled trials have shown that controlling hypertension reduces the risk of stroke, coronary artery disease, congestive heart failure, end-stage renal disease, peripheral vascular disease, as well as overall mortality. |
| PubMedID- 22762711 | Baseline clinical characteristics were similar except for higher dyslipidemia, systemic hypertension, and family history of coronary artery disease in the ees group. |
| PubMedID- 21985540 | Management of hypertension in patients with coronary artery disease. |
| PubMedID- 25829340 | Treatment of hypertension in patients with coronary artery disease: a scientific statement from the american heart association, american college of cardiology, and american society of hypertension. |
| PubMedID- 25279324 | Association of hypertension with coronary artery disease onset in the lebanese population. |
| PubMedID- 24672188 | Ninety five patients (94.06%) were only hypertensive and 6 (5.94%) had hypertension with history of coronary artery disease; mean duration (±sd) of hypertension was 42.50 (48.07) months. |
| PubMedID- 21645399 | Subsequently, cardiac catherization confirmed an exercise-induced elevation in pasp and diagnosed pulmonary arterial hypertension without evidence of coronary artery disease. |
| PubMedID- 23673899 | Conclusions: a combination of beta-blocker and diuretic is still commonly used in the treatment of hypertension in patients without coronary artery disease and heart failure. |
| PubMedID- 22093163 | Myocardial ischemia may arise in hypertension independent of coronary artery disease through an interaction between several pathophysiological mechanisms, including left ventricular hypertrophy, increased arterial stiffness and reduced coronary flow reserve associated with microvascular disease and endothelial dysfunction. |
| PubMedID- 24167376 | Information on height, weight, body mass index, cigarette smoking, hypertension, diabetes, family history of coronary artery disease, and diabetes was collected using a structured questionnaire. |
| PubMedID- 24688992 | Exclusion criteria were diabetes mellitus, arterial hypertension, and evidence of coronary artery disease, atrial fibrillation, lung disease, and inadequate echocardiograms. |
| PubMedID- 21224080 | Coronary artery disease in patients with hypertension is increasing worldwide and leads to severe cardiovascular complications. |
| PubMedID- 25880433 | Recent studies found an association between pre-hypertension and increased risk of coronary artery disease [11,12]. |
| PubMedID- 19012977 | Obese patients were younger, less often white, had more diabetes, hypertension, hyperlipidemia, family history of coronary artery disease, and congestive heart failure but fewer strokes, less peripheral vascular disease, and less often smoked. |
| PubMedID- 23720247 | Background: angina and hypertension are common in patients with coronary artery disease (cad); however, the effect on mortality is unclear. |
| PubMedID- 25425288 | Comorbidities were common in the studied population: hypertension in 72 % of patients, coronary artery disease in 31 %, diabetes in 25 %, atrial fibrillation in 21 % and cardiac insufficiency in 16 %. |
| PubMedID- 26523960 | Study design: a 66 year-old male with long standing hiv infection, hypertension, and no history of coronary artery disease (cad) presented for revision spinal fusion surgery with the use of txa, is presented. |
| PubMedID- 25828847 | Treatment of hypertension in patients with coronary artery disease: a scientific statement from the american heart association, american college of cardiology, and american society of hypertension. |
| PubMedID- 22962586 | Adjusted for hba1c, bmi, cholesterol, triglycerides, ldl, hdl, hypertension, dyslipidemia, family history of coronary artery disease, smoking, microalbuminuria/macroalbuminuria, pharmacologic treatment, and autonomic dysfunction. |
| PubMedID- 24042256 | The risk factors included smoking, hypertension, dyslipidemia, family history of coronary artery disease, and proteinuria. |
| PubMedID- 23096191 | It can be used as an alternative to cta for screening for renal artery disease, especially in patients with hypertension and renal insufficiency. |
| PubMedID- 23588030 | Additional and unresolved problems posed by arterial hypertension in patients with stable coronary artery disease regard the benefits of antihypertensive treatment due to reports of irrelevant, if not detrimental, effect of blood pressure (bp) lowering in averting coronary relapses as well as the lack of association between bp levels and incident coronary events in survivors from acute myocardial infarction. |
| PubMedID- 25840655 | Treatment of hypertension in patients with coronary artery disease: a scientific statement from the american heart association, american college of cardiology, and american society of hypertension. |
| PubMedID- 22840916 | While hypertension increases the risk of coronary artery disease in inflammatory bowel disease patients, other typical risk factors have not been confirmed, and markers of inflammation may predict coronary artery disease risk in this population. |
| PubMedID- 26425362 | Significant association of central obesity, hypertension and dyslipidemia with coronary artery diseases has been reported in numbers of ethnic population worldwide and demonstrated that these multiple risk factors have played a positive role to develop the cardiovascular diseases [2,17,19–23]. |
| PubMedID- 25984328 | It has been shown that hypertension patients with coronary artery disease have reduced levels and migratory capacity of epcs [48]. |
| PubMedID- 24199618 | The patient had only hypertension and no history of coronary artery disease, diabetes or smoking. |
| PubMedID- 22511654 | Previous analyses in for example heart failure or coronary artery disease populations (with or without hypertension) demonstrated a reduction in cardiovascular events, stroke, and mortality.36,37 in addition, a pooled analysis of trials in patients with cardiovascular disease (including hypertension) concluded that the reduction in cardiovascular mortality and stroke with raas inhibitors is bp dependent.38 in our analyses, the significant reduction in cardiovascular mortality associated with raas inhibition supports previous literature. |
| PubMedID- 24339651 | His other comorbidities include hypertension and a history of stable coronary artery disease. |
| PubMedID- PMC2934129 | The most common single etiology was vavular heart disease, the most common triple etiology was coronary artery disease complicated with hypertension and diabetes mellitus. |
| PubMedID- 25835002 | Effects of verapamil sr and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil sr-trandolapril ambulatory monitoring substudy. |
Page: 1 2